Expression of pendrin in benign and malignant human thyroid tissues
2005

Pendrin Expression in Thyroid Tissues

Sample size: 155 publication Evidence: moderate

Author Information

Author(s): Skubis-Zegadło J, Nikodemska A, Przytuła E, Mikula M, Bardadin K, Ostrowski J, Wenzel B E, Czarnocka B

Primary Institution: Medical Centre for Postgraduate Education, Warsaw, Poland

Hypothesis

The study investigates the expression of pendrin in benign and malignant human thyroid tissues.

Conclusion

Pendrin is expressed in most differentiated thyroid tumors, but its proper localization to the apical membrane is disrupted in cancerous tissues.

Supporting Evidence

  • Pendrin mRNA was detected in 92.4% of thyroid carcinomas.
  • Pendrin protein was found in 73.3% of follicular thyroid carcinomas and 76.7% of papillary thyroid carcinomas.
  • The relative mRNA expression of pendrin was lower in cancers than in normal thyroid tissues.

Takeaway

This study looked at a protein called pendrin in thyroid tissues and found that while it's usually present in healthy cells, it often gets stuck inside cancer cells instead of reaching the surface where it should be.

Methodology

The study used immunohistochemistry, Western blot, and quantitative RT-PCR to analyze pendrin expression in thyroid tissues.

Limitations

The study did not explore the mechanisms behind pendrin mislocalization in cancerous tissues.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602628

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication